mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target. - Wikidata - awgldk - TriplyDB

mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target.

mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target.

http://www.wikidata.org/entity/Q41858959

about

Dual mTOR Inhibition Is Required to Prevent TGF-β-Mediated Fibrosis: Implications for Scleroderma Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation.The PI3K/Akt/PTEN/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis?Proteogenomic analysis of psoriasis reveals discordant and concordant changes in mRNA and protein abundance.Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.Psoriatic arthritis under a proteomic spotlight: application of novel technologies to advance diagnosis and management.Upregulation of PI3K/AKT/mTOR, FABP5 and PPARβ/δ in Human Psoriasis and Imiquimod-induced Murine Psoriasiform Dermatitis Model.Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes.TNF stimulates IL-6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin.

P2860

Q28264437-6977677D-78E5-4AD2-9652-CE76A12E2841 Q33897776-6742518E-6632-4555-89E0-9FF9B545B3CD Q35680138-813EA426-7D6B-464B-9F93-BB93B7367813 Q35922976-80064966-80FE-42F3-8A53-977F57D64D48 Q37649641-0887A0D8-BC92-4273-B0D6-E41747151949 Q38431361-D653D50A-2804-4BDF-9E8B-9E1346A40C6A Q41211068-ADEDC130-9D5F-4545-8508-46B4B4815EE0 Q48326461-6E375E51-9590-458B-AC1D-E9298D4472A8 Q48362769-B1C95C8F-B625-4225-AEB6-D00BB4E17023

P2860

mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target.

http://www.wikidata.org/entity/Q41858959

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

mTOR Signaling Cascade in Psor ...... or a Novel Therapeutic Target.

@en

type

label

mTOR Signaling Cascade in Psor ...... or a Novel Therapeutic Target.

@en

prefLabel

mTOR Signaling Cascade in Psor ...... or a Novel Therapeutic Target.

@en

P1433

Q41858959-7FDB8CC7-DC8F-4705-8CEF-31D11EBDB522

P1476

Q41858959-D21B12D6-1F68-4497-8604-346AAEBBF583

P2093

Q41858959-1184EFBD-BD3B-48B4-82A0-C3367605CC99

Q41858959-E613A985-747A-4CD8-957D-B457FB3ED0A0

P2860

Q41858959-017E7BFA-83E5-4598-ABC9-6A5E5267BA07

Q41858959-02FC1BA4-A932-4572-A538-1FF27768531B

Q41858959-08A6882E-E3B3-4253-89D1-1E4EBA1097ED

Q41858959-24888076-D94A-42D2-BAF7-991C9ED141A3

Q41858959-315E4FF7-1563-4F69-88A5-57BE8ACDB16B

Q41858959-3DF1FCF2-9857-4F8B-9BC6-CB66D5ADC886

Q41858959-450DA909-1023-43DC-B122-C62C8D91DDDA

Q41858959-49C6C9E0-96F8-438B-B888-C6C2D04478C6

Q41858959-716BE6E4-5BC9-4759-8D4F-3A1FEF7BDE2E

Q41858959-71CFADAD-74A0-45F1-8CF8-AC828EF1A741

P304

Q41858959-AB801818-102F-4894-9E4F-3BEB426E8DD5

P31

Q41858959-615263AD-A973-4CF6-8D6B-169653D4AEA1

P356

Q41858959-3B55F15B-F6DA-47CD-A870-9DA56FF03B77

P407

Q41858959-0C2FB69D-7E79-4EC6-A570-F7DFC4CF41BB

P433

Q41858959-0646A669-2D57-4ADD-85B1-F7A0469CF876

P478

Q41858959-AF9B1BFB-E7A6-4970-8957-2A7FDB200F40

P577

Q41858959-CEE56A80-747F-4351-88C6-69F647340522

P698

Q41858959-1A363D33-6008-4F39-8A1F-5DA1B837FC52

P932

Q41858959-0D8CFDEB-71AD-421D-A3AE-80D0468CF58F

P356

0019-5154.123499

P1433

Indian Journal of Dermatology

P1476

mTOR Signaling Cascade in Psor ...... or a Novel Therapeutic Target.

@en

P2093

Siba P Raychaudhuri

http://www.w3.org/2001/XMLSchema#string

Smriti K Raychaudhuri

http://www.w3.org/2001/XMLSchema#string

P2860

Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1

AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas

Signaling by target of rapamycin proteins in cell growth control

Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation

TOR signaling in growth and metabolism

Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2

Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt

Regulation of cell death protease caspase-9 by phosphorylation

Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial.

Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia.

P304

67-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0019-5154.123499

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24470663

http://www.w3.org/2001/XMLSchema#string

P932

3884931

http://www.w3.org/2001/XMLSchema#string